सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

CDSCO Approves Novo Nordisk’s Wegovy for Fatty Liver Disease in India

GS2Polity · Governance · IR· Health policy & public health· Prelims·

Why in news

The CDSCO approved Novo Nordisk’s Wegovy (semaglutide) as the first injectable GLP-1 therapy in India specifically for treating Metabolic Dysfunction-Associated Steatohepatitis (MASH).

Background

The Central Drugs Standard Control Organisation (CDSCO) approved Wegovy (semaglutide 2.4 mg) for adults with moderate to advanced liver fibrosis. The approval is based on the ESSENCE trial, which showed a 63% resolution of steatohepatitis and a 37% reduction in fibrosis.

Facts for Prelims

  • BodyCDSCO: The national regulatory body for cosmetics, pharmaceuticals, and medical devices in India.
  • S&TSemaglutide: A GLP-1 (glucagon-like peptide-1) receptor agonist used to treat obesity and metabolic disorders.
  • FactWegovy dosage: Approved at 2.4 mg via injection for MASH treatment.
  • FactESSENCE Trial: Clinical trial demonstrating 63% steatohepatitis resolution and 37% fibrosis reduction.

For Mains

Q. Discuss the significance of GLP-1 receptor agonists in managing metabolic disorders and the role of regulatory bodies in ensuring the safety of novel pharmaceutical therapies in India.

Dimensions to cover in your answer

  • Regulatory oversight: Balancing rapid approval of novel biotech drugs with rigorous safety monitoring for chronic metabolic conditions
  • Accessibility gap: High cost of proprietary injectable therapies vs. the need for affordable healthcare for metabolic diseases

Keywords: Metabolic Dysfunction-Associated Steato… · GLP-1 Receptor Agonists · Regulatory Approval · Pharmaceutical Innovation · Non-communicable Diseases

Read the full news →Report a mistake in this noteHow notes are madeSource: Indian Express ↗Also: GS3 · Biotechnology & health researchAlso: GS2 · Statutory, regulatory & quasi-judicial bodies

More Social Justice notes

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.